Skip links



Full Name Mifepristone
Drug Mifepristone
Manufacturer Generic
Route of Administration Oral
Site of Care Home
Approved Indication Control hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing’s syndrome who have type 2 diabetes mellitus or glucose intolerance and have failed surgery or are not candidates for surgery
Disease Cushing’s Syndrome
Therapeutic Area Endocrinology
Enrollment Form Link Mifepristone Enrollment Form
Phone Number (888) 204-7730
Fax Number (877) 218-6288
Product Website